JPM 2022: Novartis rewrites the drug launch playbook with Leqvio, and it doesn’t plan to stop there, exec says
JPM 2022: Novartis rewrites the drug launch playbook with Leqvio, [...]
Performance Cell picked up by private equity firm, rebrands as Cellipont Bioservices
Performance Cell picked up by private equity firm, rebrands as [...]
JPM22, Day 3: Eli Lilly weighs dual branding for diabetes hopeful tirzepatide
JPM22, Day 3: Eli Lilly weighs dual branding for diabetes [...]
For Biogen’s Aduhelm, narrow coverage from CMS ‘could effectively spell the end’: analyst
For Biogen’s Aduhelm, narrow coverage from CMS ‘could effectively spell [...]
Selecta taps Ginkgo to create better capsids for gene therapy delivery
Selecta taps Ginkgo to create better capsids for gene therapy [...]
Kyowa sells U.S. rights to cancer drug delivery patch to Cumberland
Kyowa sells U.S. rights to cancer drug delivery patch to [...]
Recipharm unloads a pair of plants in separate deals as part of its streamlining, growth strategy
Recipharm unloads a pair of plants in separate deals as [...]
Eyeing its post-Humira future, AbbVie angles for broader Rinvoq use in U.S., Europe
Eyeing its post-Humira future, AbbVie angles for broader Rinvoq use [...]
#JPM22, Day 1: Bristol Myers Squibb’s blockbuster losses of exclusivity, Novartis’ spending plans and more
#JPM22, Day 1: Bristol Myers Squibb’s blockbuster losses of exclusivity, [...]
Catalent FDA write-up ‘allegedly’ the culprit behind Novo Nordisk’s Wegovy supply woes: report
Catalent FDA write-up ‘allegedly’ the culprit behind Novo Nordisk’s Wegovy [...]